- Home
- SFWL vs TELA Comparison
SFWL vs TELA Comparison
Compare SFWL & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFWL
- TELA
- Stock Information
- Founded
- SFWL 2001
- TELA 2012
- Country
- SFWL China
- TELA United States
- Employees
- SFWL N/A
- TELA N/A
- Industry
- SFWL Trucking Freight/Courier Services
- TELA Medical/Dental Instruments
- Sector
- SFWL Industrials
- TELA Health Care
- Exchange
- SFWL Nasdaq
- TELA Nasdaq
- Market Cap
- SFWL 80.8M
- TELA 92.2M
- IPO Year
- SFWL 2023
- TELA 2019
- Fundamental
- Price
- SFWL $0.98
- TELA $1.22
- Analyst Decision
- SFWL
- TELA Strong Buy
- Analyst Count
- SFWL 0
- TELA 4
- Target Price
- SFWL N/A
- TELA $6.00
- AVG Volume (30 Days)
- SFWL 10.3K
- TELA 420.5K
- Earning Date
- SFWL 04-08-2025
- TELA 03-20-2025
- Dividend Yield
- SFWL N/A
- TELA N/A
- EPS Growth
- SFWL 4.79
- TELA N/A
- EPS
- SFWL 0.13
- TELA N/A
- Revenue
- SFWL $504,158,000.00
- TELA $69,300,000.00
- Revenue This Year
- SFWL N/A
- TELA $38.03
- Revenue Next Year
- SFWL N/A
- TELA $24.38
- P/E Ratio
- SFWL $7.43
- TELA N/A
- Revenue Growth
- SFWL 24.75
- TELA 18.56
- 52 Week Low
- SFWL $0.81
- TELA $1.15
- 52 Week High
- SFWL $2.23
- TELA $6.50
- Technical
- Relative Strength Index (RSI)
- SFWL 42.77
- TELA 20.53
- Support Level
- SFWL $0.96
- TELA $1.15
- Resistance Level
- SFWL $1.04
- TELA $1.37
- Average True Range (ATR)
- SFWL 0.04
- TELA 0.18
- MACD
- SFWL -0.00
- TELA -0.09
- Stochastic Oscillator
- SFWL 23.56
- TELA 5.63
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. The company offers contract logistics services comprising planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The integrated logistics solution services of the company are comprised of three segments: B2B freight transportation; cloud storage; and value-added services.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.